好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Fall Conference | C14 - Why Should I Be Using Data from the Neurology Compensation and Productivity Survey in My Practice?

Saturday 11/06/21
10:00 AM - 11:30 AM EDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Brad C. Klein, MD, MBA, FAAN, Pearce J. Korb, MD, FAAN, David A. Evans, MBA
Practice, Policy, and Ethics
Learn to use internal and external data, including the AAN鈥檚聽 Neurology Compensation and Productivity (NCP) survey, to find and define benchmarks to improve your financial practices.
1.50 CME credits
Practice-based Learning and Improvement
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Audience Participation

Program Materials Program Evaluations

Event Timeline
10:00 AM - 11:20 AM EDT Speaker NCP Benchmarking
Melissa Yu, MD, FAAN, David A. Evans, MBA
11:20 AM - 11:30 AM EDT Q&A Live Q&A
Brad C. Klein, MD, MBA, FAAN, Pearce J. Korb, MD, FAAN, Melissa Yu, MD, FAAN, David A. Evans, MBA
Faculty Disclosures
Brad C. Klein, MD, MBA, FAAN Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to AAN interests or activities.
Pearce J. Korb, MD, FAAN Dr. Korb has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical 好色先生 Resources.
Melissa Yu, MD, FAAN An immediate family member of Dr. Yu has received personal compensation for serving as an employee of CVS/Aetna. The institution of Dr. Yu has received research support from Alzheimer's Association. The institution of Dr. Yu has received research support from Biogen. The institution of Dr. Yu has received research support from Eisai. The institution of Dr. Yu has received research support from Novo Nordisk. The institution of Dr. Yu has received research support from Suven. The institution of Dr. Yu has received research support from AriBio.
David A. Evans, MBA Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics/Amgen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro. Mr. Evans has stock in NeuroDiscovery.AI.